Anacor Pharmaceuticals is a California-based company that specializes in the development and commercialization of novel therapies for various dermatological conditions. The company's products use its proprietary boron chemistry platform, allowing it to create unique drugs that are highly effective and safe for patients. Uses: Anacor Pharmaceuticals is known for its flagship product, Crisaborole, which is sold under the brand name Eucrisa. Crisaborole is a non-steroidal topical ointment that is used to treat mild-to-moderate eczema in both children and adults. Eczema is a chronic skin condition characterized by itching, redness, and scaling of the skin. It is caused by an overactive immune response in the skin, leading to inflammation and damage. Crisaborole works by inhibiting an enzyme called PDE-4, which plays a crucial role in the development of inflammation in eczema. This, in turn, lowers inflammation and helps to reduce the symptoms of eczema. Dosage: Crisaborole is available as a 2% topical ointment, and the recommended dosage is to apply a thin layer of the ointment to the affected area twice daily. The ointment is for external use only and should not be applied to open wounds or broken skin. Side effects: Like all medications, Crisaborole can cause side effects, although not everyone experiences them. The most common side effect of Crisaborole is application site pain, which is usually mild or moderate in intensity. Other less common side effects include dry skin, itching, and redness at the application site. Interactions: Crisaborole has no known drug interactions. However, it is important to inform your doctor of all medications you are taking before starting treatment with Crisaborole. Generic: Crisaborole is an FDA-approved medication and an innovative product that has proven to be effective in treating eczema. Currently, there are no generic versions of Crisaborole available on the market. Demographic: Crisaborole is approved for use in patients aged two years and above, making it suitable for children and adults with mild-to-moderate eczema. Conclusion: In conclusion, Anacor Pharmaceuticals is a leading company that specializes in the development of topical dermatological medications. Crisaborole is their flagship product and has proven to be highly effective in treating mild-to-moderate eczema. It works by inhibiting the PDE-4 enzyme, which lowers inflammation and reduces the symptoms of eczema. Crisaborole is a safe medication that is suitable for children and adults aged two years and above. However, it is important to follow the recommended dosage and inform your doctor of all medications you are taking before starting treatment.